Objective: The aim of this research work is to determine the rate of occurrence and prognosticators of pulmonary HTN (Hypertension) among patients suffering from Systemic Lupus Erythematosus. Methodology: This research work was carried out at Hayatabad Medical Complex, Peshawar from July 2019 to December 2019. In this study 97 patients who fulfilled the standard of ACR (American College of Rheumatology) for systemic lupus erythematosus got recruitment for this research work. The measurement of PAH (Pulmonary Arterial Hypertension) was carried out with the calculation of the pulmonary arterial SBP (Systolic Blood Pressure) through ECG (Echocardiography) by cardiologist. We collected the characteristics of demography and disease in an organ...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
Objective: The aim of this study is to determine the rate of occurrence and prognosticators of pulmo...
Abstract Background No population-based study has investigated the cumulative incidence of pulmonary...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
Objectives: This study aims to identify the factors associated with the development and mortality of...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
Objective: The aim of this study is to determine the rate of occurrence and prognosticators of pulmo...
Abstract Background No population-based study has investigated the cumulative incidence of pulmonary...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
Objectives: This study aims to identify the factors associated with the development and mortality of...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...
International audienceBACKGROUND: Pulmonary arterial hypertension (PAH) is a rare complication of sy...